Cargando…
Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes
[Image: see text] The recent global wave of organic food consumption and the vitality of nutraceuticals for human health benefits has driven the need for applying scientific methods for phytochemical testing. Advanced in vitro models with greater physiological relevance than conventional in vitro mo...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483668/ https://www.ncbi.nlm.nih.gov/pubmed/37692213 http://dx.doi.org/10.1021/acsomega.3c03155 |
_version_ | 1785102430248108032 |
---|---|
author | Farooqi, Muhammad Awais Kang, Chul-Ung Choi, Kyung Hyun |
author_facet | Farooqi, Muhammad Awais Kang, Chul-Ung Choi, Kyung Hyun |
author_sort | Farooqi, Muhammad Awais |
collection | PubMed |
description | [Image: see text] The recent global wave of organic food consumption and the vitality of nutraceuticals for human health benefits has driven the need for applying scientific methods for phytochemical testing. Advanced in vitro models with greater physiological relevance than conventional in vitro models are required to evaluate the potential benefits and toxicity of nutraceuticals. Organ-on-chip (OOC) models have emerged as a promising alternative to traditional in vitro models and animal testing due to their ability to mimic organ pathophysiology. Numerous studies have demonstrated the effectiveness of OOC models in identifying pharmaceutically relevant compounds and accurately assessing compound-induced toxicity. This review examines the utility of traditional in vitro nutraceutical testing models and discusses the potential of OOC technology as a preclinical testing tool to examine the biomedical potential of nutraceuticals by reducing the need for animal testing. Exploring the capabilities of OOC models in carrying out plant-based bioactive compounds can significantly contribute to the authentication of nutraceuticals and drug discovery and validate phytochemicals medicinal characteristics. Overall, OOC models can facilitate a more systematic and efficient assessment of nutraceutical compounds while overcoming the limitations of current traditional in vitro models. |
format | Online Article Text |
id | pubmed-10483668 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-104836682023-09-08 Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes Farooqi, Muhammad Awais Kang, Chul-Ung Choi, Kyung Hyun ACS Omega [Image: see text] The recent global wave of organic food consumption and the vitality of nutraceuticals for human health benefits has driven the need for applying scientific methods for phytochemical testing. Advanced in vitro models with greater physiological relevance than conventional in vitro models are required to evaluate the potential benefits and toxicity of nutraceuticals. Organ-on-chip (OOC) models have emerged as a promising alternative to traditional in vitro models and animal testing due to their ability to mimic organ pathophysiology. Numerous studies have demonstrated the effectiveness of OOC models in identifying pharmaceutically relevant compounds and accurately assessing compound-induced toxicity. This review examines the utility of traditional in vitro nutraceutical testing models and discusses the potential of OOC technology as a preclinical testing tool to examine the biomedical potential of nutraceuticals by reducing the need for animal testing. Exploring the capabilities of OOC models in carrying out plant-based bioactive compounds can significantly contribute to the authentication of nutraceuticals and drug discovery and validate phytochemicals medicinal characteristics. Overall, OOC models can facilitate a more systematic and efficient assessment of nutraceutical compounds while overcoming the limitations of current traditional in vitro models. American Chemical Society 2023-08-21 /pmc/articles/PMC10483668/ /pubmed/37692213 http://dx.doi.org/10.1021/acsomega.3c03155 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Farooqi, Muhammad Awais Kang, Chul-Ung Choi, Kyung Hyun Organ-on-Chip: Advancing Nutraceutical Testing for Improved Health Outcomes |
title | Organ-on-Chip:
Advancing Nutraceutical Testing for
Improved Health Outcomes |
title_full | Organ-on-Chip:
Advancing Nutraceutical Testing for
Improved Health Outcomes |
title_fullStr | Organ-on-Chip:
Advancing Nutraceutical Testing for
Improved Health Outcomes |
title_full_unstemmed | Organ-on-Chip:
Advancing Nutraceutical Testing for
Improved Health Outcomes |
title_short | Organ-on-Chip:
Advancing Nutraceutical Testing for
Improved Health Outcomes |
title_sort | organ-on-chip:
advancing nutraceutical testing for
improved health outcomes |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483668/ https://www.ncbi.nlm.nih.gov/pubmed/37692213 http://dx.doi.org/10.1021/acsomega.3c03155 |
work_keys_str_mv | AT farooqimuhammadawais organonchipadvancingnutraceuticaltestingforimprovedhealthoutcomes AT kangchulung organonchipadvancingnutraceuticaltestingforimprovedhealthoutcomes AT choikyunghyun organonchipadvancingnutraceuticaltestingforimprovedhealthoutcomes |